Bank of America’s NRC Health Common Stock NRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.91M Buy
112,468
+3,323
+3% +$56.5K ﹤0.01% 4148
2025
Q4
$2.05M Sell
109,145
-10,083
-8% -$152K ﹤0.01% 4045
2025
Q3
$1.52M Sell
119,228
-3,116
-3% -$46.7K ﹤0.01% 5038
2025
Q2
$2.06M Buy
122,344
+6,690
+6% +$90.4K ﹤0.01% 4748
2025
Q1
$1.48M Buy
115,654
+3,997
+4% +$64.2K ﹤0.01% 4942
2024
Q4
$1.97M Sell
111,657
-7,157
-6% -$136K ﹤0.01% 4461
2024
Q3
$2.72M Sell
118,814
-2,131
-2% -$48.1K ﹤0.01% 4301
2024
Q2
$2.78M Sell
120,945
-3,378
-3% -$104K ﹤0.01% 4163
2024
Q1
$4.92M Buy
124,323
+17,831
+17% +$705K ﹤0.01% 3624
2023
Q4
$4.21M Sell
106,492
-2,057
-2% -$86.1K ﹤0.01% 3691
2023
Q3
$4.82M Buy
108,549
+566
+0.5% +$24.7K ﹤0.01% 3445
2023
Q2
$4.7M Sell
107,983
-2,092
-2% -$92K ﹤0.01% 3472
2023
Q1
$4.79M Buy
110,075
+12,189
+12% +$538K ﹤0.01% 3580
2022
Q4
$3.65M Sell
97,886
-6,300
-6% -$244K ﹤0.01% 3698
2022
Q3
$4.14M Buy
104,186
+7,495
+8% +$277K ﹤0.01% 3531
2022
Q2
$3.7M Sell
96,691
-3,579
-4% -$129K ﹤0.01% 3722
2022
Q1
$3.98M Buy
100,270
+14,131
+16% +$553K ﹤0.01% 3876
2021
Q4
$3.58M Buy
86,139
+19,284
+29% +$838K ﹤0.01% 3998
2021
Q3
$2.82M Buy
66,855
+9,232
+16% +$465K ﹤0.01% 4117
2021
Q2
$2.65M Buy
57,623
+12,283
+27% +$584K ﹤0.01% 4087
2021
Q1
$2.12M Buy
45,340
+29,718
+190% +$1.44M ﹤0.01% 4203
2020
Q4
$668K Sell
15,622
-3,789
-20% -$195K ﹤0.01% 4806
2020
Q3
$956K Buy
19,411
+3,271
+20% +$181K ﹤0.01% 4249
2020
Q2
$939K Buy
16,140
+6,309
+64% +$333K ﹤0.01% 4161
2020
Q1
$447K Buy
9,831
+779
+9% +$46.8K ﹤0.01% 4579
2019
Q4
$597K Sell
9,052
-2,210
-20% -$135K ﹤0.01% 4896
2019
Q3
$651K Sell
11,262
-386
-3% -$23.9K ﹤0.01% 4883
2019
Q2
$670K Buy
11,648
+2,045
+21% +$94.6K ﹤0.01% 4861
2019
Q1
$371K Sell
9,603
-5,783
-38% -$227K ﹤0.01% 5202
2018
Q4
$587K Buy
15,386
+3,882
+34% +$149K ﹤0.01% 4826
2018
Q3
$444K Buy
11,504
+4,827
+72% +$183K ﹤0.01% 5037
2018
Q2
$249K Sell
6,677
-1,093
-14% -$38.1K ﹤0.01% 5287
2018
Q1
$227K Buy
7,770
+2,894
+59% +$97.1K ﹤0.01% 5300
2017
Q4
$181K Buy
4,876
+2,243
+85% +$79.6K ﹤0.01% 5456
2017
Q3
$100K Sell
2,633
-1,830
-41% -$57.5K ﹤0.01% 5674
2017
Q2
$120K Sell
4,463
-1,259
-22% -$30.8K ﹤0.01% 5537
2017
Q1
$112K Buy
5,722
+2,405
+73% +$44.5K ﹤0.01% 5567
2016
Q4
$63K Buy
3,317
+382
+13% +$6.31K ﹤0.01% 5834
2016
Q3
$48K Sell
2,935
-266
-8% -$4.18K ﹤0.01% 5750
2016
Q2
$44K Buy
3,201
+1,036
+48% +$14.6K ﹤0.01% 5880
2016
Q1
$34K Sell
2,165
-237
-10% -$3.47K ﹤0.01% 5924
2015
Q4
$39K Buy
2,402
+208
+9% +$3.16K ﹤0.01% 6152
2015
Q3
$26K Sell
2,194
-327
-13% -$4.34K ﹤0.01% 6225
2015
Q2
$36K Buy
2,521
+331
+15% +$4.69K ﹤0.01% 6096
2015
Q1
$32K Buy
+2,190
New +$30.9K ﹤0.01% 5847
2014
Q3
Sell
-1,722
Closed -$24K 8110
2014
Q2
$24K Buy
1,722
+1,709
+13,146% +$25.7K ﹤0.01% 7087
2014
Q1
$0 Sell
13
-7
-35% -$117 ﹤0.01% 7979
2013
Q4
$0 Sell
20
-150
-88% -$2.63K ﹤0.01% 8050
2013
Q3
$3K Sell
170
-1,232
-88% -$21.2K ﹤0.01% 7543
2013
Q2
$25K Buy
+1,402
New +$22.4K ﹤0.01% 6878

Other funds holding NRC

Bank of America's NRC Position: Q1 2026 in Review

Bank of America increased its NRC Health Common Stock (NRC) stake by 3% in Q1 2026, buying an estimated $56.5K and bringing the position to 112,468 shares worth $1.91M. The position accounts for ﹤0.01% of the portfolio, ranked #4148.

Bank of America first reported a position in NRC in Q2 2013 and has held it in 50 quarters since. The position peaked at $4.92M in Q1 2024. 121 funds tracked by Wall St. Rank hold NRC as of Q1 2026.

  • Bank of America held 112,468 shares of NRC Health Common Stock worth $1.91M as of Q1 2026.
  • Bank of America bought 3,323 NRC Health Common Stock shares in Q1 2026, an estimated $56.5K.
  • NRC Health Common Stock made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #4148 holding.
  • Bank of America first reported a position in NRC Health Common Stock in Q2 2013 and has held it in 50 quarters since.
  • Bank of America's NRC Health Common Stock position peaked at $4.92M in Q1 2024.
  • 121 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.